Complete financial analysis of Oramed Pharmaceuticals Inc. (ORMP.TA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Oramed Pharmaceuticals Inc., a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- Jenscare Scientific Co., Ltd. (9877.HK) Income Statement Analysis – Financial Results
- Argus Worldwide Corp. (ARGW) Income Statement Analysis – Financial Results
- Strategic Elements Ltd (SORHF) Income Statement Analysis – Financial Results
- Bil Energy Systems Limited (BILENERGY.NS) Income Statement Analysis – Financial Results
- Calissio Resources Group, Inc. (CRGP) Income Statement Analysis – Financial Results
Oramed Pharmaceuticals Inc. (ORMP.TA)
About Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. The company's product portfolio includes ORMD-0801 Type 2, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes; ORMD-0801, Phase 2 oral insulin capsule for non-alcoholic steatohepatitis, a progressive liver diseases; and ORMD-0901, an oral glucagon-like peptide-1 capsule that has completed phase I clinical trials for the treatment of type 2 diabetes. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.70M | 2.70M | 2.71M | 2.70M | 2.45M | 2.46M | 641.00K | 0.00 | 0.00 | 0.00 | 184.25K | 197.41K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 90.00K | 90.00K | 86.00K | 187.00K | 490.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 2.70M | 2.70M | 2.62M | 2.61M | 2.36M | 2.27M | 151.00K | 0.00 | 0.00 | 0.00 | 184.25K | 197.41K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 100.00% | 100.00% | 96.68% | 96.67% | 103.51% | 92.39% | 23.56% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 27.64M | 20.99M | 10.24M | 13.52M | 11.98M | 10.28M | 7.71M | 4.78M | 3.28M | 2.27M | 1.68M | 1.16M | 1.46M | 1.52M | 1.18M | 2.21M | 197.75K | 0.00 | 0.00 | 10.00K |
| General & Administrative | 13.81M | 5.94M | 4.23M | 3.72M | 4.08M | 2.76M | 2.45M | 2.60M | 2.63M | 2.03M | 1.20M | 1.28M | 1.51M | 1.26M | 1.50M | 918.00K | 215.14K | 44.81K | 280.00K | 50.00K |
| Selling & Marketing | 1.85M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 15.66M | 5.94M | 4.23M | 3.72M | 4.08M | 2.76M | 2.45M | 2.60M | 2.63M | 2.03M | 1.20M | 1.28M | 1.51M | 1.26M | 1.50M | 918.00K | 215.14K | 44.81K | 280.00K | 50.00K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 440.00K | -10.00K |
| Operating Expenses | 43.30M | 26.93M | 14.47M | 17.24M | 16.06M | 13.04M | 10.16M | 7.38M | 5.91M | 4.30M | 2.88M | 2.44M | 2.97M | 2.78M | 2.68M | 3.13M | 412.88K | 44.81K | 720.00K | 50.00K |
| Cost & Expenses | 43.30M | 26.93M | 14.47M | 17.33M | 15.98M | 13.23M | 10.65M | 7.38M | 5.91M | 4.30M | 2.88M | 2.44M | 2.97M | 2.78M | 2.68M | 3.13M | 412.88K | 44.81K | 720.00K | 50.00K |
| Interest Income | 3.57M | 347.00K | 690.00K | 1.06M | 903.00K | 785.00K | 474.00K | 168.00K | 225.00K | 18.73K | 13.13K | 33.23K | 24.69K | 38.60K | -83.19K | -11.00K | 1.99K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.00K | 313.45K | 199.12K | 18.78K | 14.54K | 17.56K | 10.28K | -3.24M | 3.68K | -44.81K | 0.00 | 0.00 |
| Depreciation & Amortization | 3.62M | 77.00K | 7.00K | 8.00K | 6.00K | 5.00K | 4.00K | 4.00K | 6.00K | 5.38K | 14.74K | 28.30K | 31.86K | 30.49K | 15.45K | 108.00K | -1.69K | -973.00 | 0.00 | 0.00 |
| EBITDA | -36.98M | -25.04M | -11.31M | -14.17M | -13.49M | -10.76M | -9.99M | -7.38M | -5.68M | -4.13M | -2.86M | -2.37M | -2.92M | -2.72M | -2.66M | -3.02M | -412.88K | -44.81K | -720.00K | -50.00K |
| EBITDA Ratio | -1,367.96% | -926.34% | -417.42% | -524.34% | -550.88% | -437.95% | -1,558.35% | 0.00% | 0.00% | 0.00% | -1,550.11% | -1,202.43% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -40.60M | -24.22M | -11.76M | -14.63M | -13.53M | -10.77M | -10.01M | -7.38M | -5.91M | -4.30M | 2.88M | -2.44M | -2.97M | -2.78M | -2.68M | -3.13M | -412.88K | -44.81K | -720.00K | -50.00K |
| Operating Income Ratio | -1,501.96% | -896.15% | -433.84% | -541.29% | -552.35% | -438.56% | -1,561.62% | 0.00% | 0.00% | 0.00% | 1,565.24% | -1,233.60% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 2.93M | 893.00K | -438.00K | -450.00K | -30.00K | -10.00K | -17.00K | -3.00K | 214.00K | -164.72K | -184.25K | 835.59K | 10.15K | 21.05K | 5.29M | -104.00K | -1.69K | -973.00 | 0.00 | 0.00 |
| Income Before Tax | -37.66M | -22.99M | -11.51M | -14.06M | -12.73M | -10.08M | -9.63M | -7.23M | -5.69M | -4.44M | -3.25M | -1.59M | -2.96M | -2.76M | 2.61M | -3.24M | -414.58K | -45.78K | -720.00K | -50.00K |
| Income Before Tax Ratio | -1,393.41% | -850.50% | -424.76% | -519.98% | -519.68% | -410.42% | -1,502.18% | 0.00% | 0.00% | 0.00% | -1,766.18% | -803.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 100.00K | -2.88M | 192.00K | 300.00K | -800.00K | 400.00K | 1.34M | -1.00K | 4.00K | -205.06K | 90.22K | -23.98K | 14.97K | -2.60K | 162.16K | 3.24M | 414.58K | 45.78K | 0.00 | 0.00 |
| Net Income | -37.76M | -22.24M | -11.51M | -14.36M | -12.73M | -10.48M | -10.96M | -7.23M | -5.70M | -4.23M | -3.34M | -1.56M | -2.98M | -2.76M | -2.77M | -3.24M | -414.58K | -45.78K | -720.00K | -50.00K |
| Net Income Ratio | -1,397.11% | -822.72% | -424.76% | -531.08% | -519.68% | -426.71% | -1,710.45% | 0.00% | 0.00% | 0.00% | -1,815.15% | -790.86% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.97 | -0.78 | -0.56 | -0.82 | -0.86 | -0.79 | -0.87 | -0.67 | -0.62 | -0.59 | -0.57 | -0.29 | -0.62 | -0.58 | -0.68 | -0.92 | -0.15 | -0.03 | -0.28 | -0.02 |
| EPS Diluted | -0.97 | -0.78 | -0.56 | -0.82 | -0.86 | -0.79 | -0.87 | -0.67 | -0.62 | -0.59 | -0.57 | -0.29 | -0.62 | -0.58 | -0.68 | -0.92 | -0.15 | -0.03 | -0.28 | -0.02 |
| Weighted Avg Shares Out | 39.00M | 28.47M | 20.53M | 17.45M | 14.88M | 13.31M | 12.62M | 10.82M | 9.24M | 7.21M | 5.88M | 5.42M | 4.78M | 4.72M | 4.05M | 3.52M | 2.78M | 1.54M | 2.54M | 2.90M |
| Weighted Avg Shares Out (Dil) | 39.00M | 28.47M | 20.53M | 17.45M | 14.88M | 13.31M | 12.62M | 10.82M | 9.24M | 7.21M | 5.88M | 5.42M | 4.78M | 4.72M | 4.05M | 3.52M | 2.78M | 1.54M | 2.54M | 2.90M |
Source: https://incomestatements.info
Category: Stock Reports